case_images: PMC11830729_01
case_images: PMC11830729_02
case_images: PMC11830729_03
case_images: PMC11830729_04
case_images: PMC11830729_05
case_images: PMC11830729_06
case_images: Timeline of primary diagnosis and pharmacological interventions. PZA, pyrazinamide; INH, isoniazid; RMP, rifampicin; EMB, ethambutol; AZA, azathioprine; Pred, prednisone; TAC, tacrolimus.
case_images: fimmu-16-1367409-g001.jpg
case_images: PMC11830729_06_fimmu-16-1367409-g001.jpg
case_images: f1
case_images: The patient's summarized diagnostic and treatment course from 2013 to 2023 is depicted in  Figure 1 , while the trend of hemoglobin levels can be seen in the line graph in  Figure 2 .
case_images: Line graph depicting trends in hemoglobin levels, significant events, and therapeutic interventions. TAC, tacrolimus.
case_images: fimmu-16-1367409-g002.jpg
case_images: PMC11830729_06_fimmu-16-1367409-g002.jpg
case_images: f2
case_images: The patient's summarized diagnostic and treatment course from 2013 to 2023 is depicted in  Figure 1 , while the trend of hemoglobin levels can be seen in the line graph in  Figure 2 .